Amag Pharmaceuticals, Inc.

This study tests a medicine called ferumoxytol for children aged 2 to 17 with iron deficiency anemia (low iron). It is for kids who cannot take iron pills or for whom pills do not work. The main goal is to see if the medicine raises hemoglobin (a part of red blood cells) safely. …

This study tests a drug called ferumoxytol to treat iron deficiency anemia in children aged 2 to 17 with chronic kidney disease. It compares ferumoxytol to another iron treatment (iron sucrose) to see which is safer and works better at raising hemoglobin levels. The goal is to fi…